SCHEMBL10703752

SCHEMBL10703752

CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 7/20 0.62
▸ LMNA P02545 5/20 0.62
▸ HIF1A Q16665 4/20 0.62
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ MAPT P10636 2/20 0.62
▸ CYP2C19 P33261 2/20 0.62
▸ CYP3A4 P08684 7/20 0.57
▸ PGR P06401 5/20 0.57
▸ DRD1 P21728 1/20 0.57
▸ OPRK1 P41145 1/20 0.57
▸ PDE3A Q14432 1/20 0.57
▸ CYP2C9 P11712 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ SHBG P04278 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ SERPINA6 P08185 2/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11795484 0.85 NR3C1 (0.56) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL10704998 0.83 NR3C1 (0.65) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL3773788 0.82 LMNA (0.67) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL3773792 0.82 LMNA (0.67) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL11799289 0.81 NR3C1 (0.61) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL10703509 0.80 NR3C1 (0.52) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL10703144 0.80 NR3C1 (0.54) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL10705558 0.79 NR3C1 (0.52) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL10702508 0.79 NR3C1 (0.63) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL10703743 0.78 NR3C1 (0.53) NR3C1LMNAHIF1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP claimed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP claimed
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP disclosed
Send feedback